Paper39479216
NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection.
Chambon M and 1 other. Transpl Int, 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection. Papers, record 39479216. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39479216
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Killer Cells, Natural | Major topic |
| Graft Rejection | Major topic |
| Humans | |
| Chronic Disease | |
| Animals | |
| Graft Survival |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07718308 | CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients | Results |
Source ClinicalTrials.gov
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37220805 | Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56dimCD16bright natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity. | Kidney Int | 2023 | https://conductscience.org/library/papers/37220805 | PubMed |
| 2 | 11466332 | IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. | J Immunol | 2001 | https://conductscience.org/library/papers/11466332 | PubMed |
| 3 | 9396765 | Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. | J Exp Med | 1997 | https://conductscience.org/library/papers/9396765 | PubMed |
| 4 | 22070565 | A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. | Am J Transplant | 2012 | https://conductscience.org/library/papers/22070565 | PubMed |
| 5 | 32641395 | Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies. | J Am Soc Nephrol | 2020 | https://conductscience.org/library/papers/32641395 | PubMed |
| 6 | 31767837 | Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants. | Nat Commun | 2019 | https://conductscience.org/library/papers/31767837 | PubMed |
| 7 | 20973913 | Long-term renal allograft survival in the United States: a critical reappraisal. | Am J Transplant | 2011 | https://conductscience.org/library/papers/20973913 | PubMed |
| 8 | 36066491 | Diminished cell proliferation promotes natural killer cell adaptive-like phenotype by limiting FcεRIγ expression. | J Exp Med | 2022 | https://conductscience.org/library/papers/36066491 | PubMed |
| 9 | 19843029 | Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway. | Am J Transplant | 2009 | https://conductscience.org/library/papers/19843029 | PubMed |
| 10 | 22105371 | CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. | Eur J Immunol | 2012 | https://conductscience.org/library/papers/22105371 | PubMed |
| 11 | 18523245 | The innate NK cells, allograft rejection, and a key role for IL-15. | J Immunol | 2008 | https://conductscience.org/library/papers/18523245 | PubMed |
| 12 | 7541798 | Interaction between lck and syk family tyrosine kinases in Fc gamma receptor-initiated activation of natural killer cells. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7541798 | PubMed |
| 13 | 21883901 | Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. | Am J Transplant | 2011 | https://conductscience.org/library/papers/21883901 | PubMed |
| 14 | 26555944 | One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial. | Transplantation | 2016 | https://conductscience.org/library/papers/26555944 | PubMed |
| 15 | 19392983 | Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival. | Am J Transplant | 2009 | https://conductscience.org/library/papers/19392983 | PubMed |
| 16 | 33239394 | Missing Self-Induced Activation of NK Cells Combines with Non-Complement-Fixing Donor-Specific Antibodies to Accelerate Kidney Transplant Loss in Chronic Antibody-Mediated Rejection. | J Am Soc Nephrol | 2021 | https://conductscience.org/library/papers/33239394 | PubMed |
| 17 | 29478298 | Functional Fc gamma receptor gene polymorphisms and donor-specific antibody-triggered microcirculation inflammation. | Am J Transplant | 2018 | https://conductscience.org/library/papers/29478298 | PubMed |
| 18 | 20659089 | NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. | Am J Transplant | 2010 | https://conductscience.org/library/papers/20659089 | PubMed |
| 19 | 30396694 | Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation. | Kidney Int | 2019 | https://conductscience.org/library/papers/30396694 | PubMed |
| 20 | 8675682 | Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8675682 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42587776 | Platelet-Derived Exosome Product Prolongs Stem Cell-Derived β-Cell Graft Survival and Is Associated with Reduced Nk Cell Infiltration and Immunomodulation. | Cells | 2026 | https://conductscience.org/library/papers/42587776 | PubMed |
| 42382225 | Not all antibodies are created equal: total IgG glycosylation and severity of antibody-mediated rejection in kidney transplantation. | Transpl Int | 2026 | https://conductscience.org/library/papers/42382225 | PubMed |
| 42201030 | Unsupervised Immune Profiling Identifies Distinct Post-Transplant T-Cell Clusters Associated with Kidney Allograft Function. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42201030 | PubMed |
| 42010035 | Immunomodulatory Strategies for Managing Viral Infections in Solid Organ Transplantation: Progress and Challenges. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42010035 | PubMed |
| 41671187 | Dual inhibition of mTOR and calcineurin pathways mitigates missing self-induced NK cell-mediated microvascular rejection. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41671187 | PubMed |
| 41634502 | Plasma exchange combined with anti-B-cell therapy enables comparable outcomes between DSA-positive and DSA-negative aplastic anemia after haplo-HSCT: a propensity-score-matched cohort study. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41634502 | PubMed |
| 41393858 | One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejection. | Clin Kidney J | 2025 | https://conductscience.org/library/papers/41393858 | PubMed |
| 40444214 | Targeting CD38 in Antibody-Mediated Rejection. | Transpl Int | 2025 | https://conductscience.org/library/papers/40444214 | PubMed |
| 40440205 | Antibody-mediated rejection-treatment standard. | Nephrol Dial Transplant | 2025 | https://conductscience.org/library/papers/40440205 | PubMed |
| 39659965 | Shedding Light on Microvascular Inflammation: Understanding Outcomes, But What Sparks the Flame? | Transpl Int | 2024 | https://conductscience.org/library/papers/39659965 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39479216
GET https://conductscience.org/api/papers/v1/39479216/references?page=2